Pentobarbital Sodium 25021-0676-20
- Manufacturer
- Sagent Pharmaceuticals
- Dosage Form
- Injection, Solution
- Route
- Intramuscular And Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- April 19, 2017
- Listing Expires
- December 31, 2026
- Application
- ANDA206404
Active Ingredients
| Ingredient | Strength |
|---|---|
| Pentobarbital Sodium | 50 mg/mL |
Selected Package
25021-0676-20Selected1 VIAL in 1 CARTON (25021-676-20) / 20 mL in 1 VIAL
Other packages for this product(1)
1 VIAL in 1 CARTON (25021-676-50) / 50 mL in 1 VIAL